To deepen our understanding of cancer progression, Evagelou et al. supported DDX28 as a tumor suppressor and prognostic marker through mechanistic insights into a negatively regulated hypoxic translation mediated by HIF-2α and eIF4E2 (Evagelou et al., 2020). The gene discussed is DDX28; the disease is neoplasm.